Anti-cancer drugs interfere with intracellular calcium signaling

NeuroToxicology

Volumn 30, Issue 5, 2009, Pages 803-810

  Florea, Ana Maria ^a,b   Büsselberg, Dietrich ^c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c Paul L Foster School of Medicine   (United States)

Author keywords

Anti cancer treatment; Arsenic trioxide; Calcium homeostasis; Cisplatin; Co application; Intracelluar calcium signaling; Trimethyltin

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC; ARSENIC TRIOXIDE; CALCIUM ION; CARBOPLATIN; CASPASE 3; CASPASE 8; CASPASE 9; CISPLATIN; NEDAPLATIN; OXALIPLATIN; PROCASPASE 3; PROTEIN BAX; PROTEIN BID; PROTEIN P53; TRIMETHYLTIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BLADDER CANCER; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL FUNCTION; CELL SPECIFICITY; ESOPHAGUS CANCER; GENOTOXICITY; HEAD AND NECK CANCER; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MUTAGENICITY; NEUROTOXICITY; OVARY CANCER; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN CLEAVAGE; REVIEW; TESTIS CANCER; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CANCER;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CALCIUM; CALCIUM SIGNALING; CARCINOGENS, ENVIRONMENTAL; EXTRACELLULAR FLUID; HUMANS; METALS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 70349728402     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.04.014     Document Type: Review

References (67)

1. Akaza H., Saijo N., Aiba K., Isonishi S., Ohashi Y., Kawai K., et al. Platinum compounds in cancer therapy-past, present, and future. Gan To Kagaku Ryoho 28 May (5) (2001) 625-635
2. Antman K.H. Introduction: the history of arsenic trioxide in cancer therapy. Oncologist 6 Suppl. 2 (2001) 1-2
3. Aronson S.M. Arsenic and old myths. R I Med 77 (1994) 233-234
4. Berridge M.J., Bootman M.D., and Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4 7 (2003) 517-529
5. Bonati A., Rizzoli V., and Lunghi P. Arsenic trioxide in hematological malignancies: the new discovery of an ancient drug. Curr Pharm Biotechnol 7 December (6) (2006) 397-405
6. Boulikas T., and Vougiouka M. Cisplatin and platinum drugs at the molecular level. Oncol Rep 10 November-December (6) (2003) 1663-1682
7. 3+. J Neurophysiol 71 April (4) (1994) 1491-1497
8. 2+)-2 divalent cations with different actions on voltage-activated calcium-channel currents. Cell Mol Neurobiol 6 (1994) 675-687
9. Büsselberg D. Calcium channels as target sites of heavy metals. Toxicol Lett 82-83 (1995) 255-261
10. Cepeda V., Fuertes M.A., Castilla J., Alonso C., Quevedo C., and Pérez J.M. Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 7 January (1) (2007) 3-18
11. Desoize B. Metals and metal compounds in cancer treatment. Anticancer Res 24 May-June (3a) (2004) 1529-1544
12. Desoize B. Cancer and metals and metal compounds: part I-carcinogenesis. Crit Rev Oncol Hematol 42 April (1) (2002) 1-3
13. Desoize B. Cancer and metals and metal compounds: part II-cancer treatment. Crit Rev Oncol Hematol 42 June (3) (2002) 213-215
14. Desoize B., and Madoulet C. Particular aspects of platinum compounds used at present in cancer treatment. Crit Rev Oncol Hematol 42 June (3) (2002) 317-325
15. Devarajan P., Savoca M., Castaneda M.P., Park M.S., Esteban-Cruciani N., Kalinec G., et al. Cisplatin-induced apoptosis in auditory cells: role of death receptor and mitochondrial pathways. Hear Res 174 December (1-2) (2002) 45-54
16. Dilda P.J., and Hogg P.J. Arsenical-based cancer drugs. Cancer Treat Rev 33 October (6) (2007) 542-564
17. Efferth T., Li P.C., Konkimalla V.S., and Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 13 August (8) (2007) 353-361
18. Florea A.M. Toxicity of alkylated derivatives of arsenic, antimony and tin: cellular uptake, cytotoxicity, genotoxic effects, perturbation of Ca2+ homeostasis and cell death (2005), Shaker Verlag, Aachen
19. i of human SY-5Y neuroblastoma and human embryonic kidney 293 (HEK) cells and induces cytotoxicity. Inaugural - Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften in der Medizin durch die Medizinische Fakultät der Universität Duisburg-Essen, Germany; 2007.
20. Florea A.M., and Büsselberg D. Toxic effects of metals: use, benefits and toxic cellular effects. Materialwiss u Werkstofft 36 (2005) 757-760
21. Florea A.M., and Büsselberg D. Occurrence, use and potential toxic effects of metals and metal compounds. Biometals 19 4 (2006) 419-427
22. Florea A.M., and Büsselberg D. Arsenic trioxide in environmentally and clinically relevant concentrations alters calcium homeostasis and induces cell type specific apoptosis in tumour and nontumor cells. Toxicol Lett 179 (2008) 34-42
23. Florea A.M., and Büsselberg D. Metal compounds (arsenic trioxide and trimehtyltin) interact with calcium homeostasis and trigger cell death in "in vitro" systems. Materialwissenschaft und Werkstofftechnik 1-2 (2009) 13-16
24. Florea A.M., Dopp E., and Büsselberg D. Elevated Ca2+(i) transients induced by trimethyltin chloride in HeLa cells: types and levels of response. Cell Calcium 37 3 (2005) 251-258
25. Florea A.M., Splettstoesser F., Dopp E., Rettenmeier A.W., and Büsselberg D. Modulation of intracellular calcium homeostasis by trimethyltin chloride in human tumor cells: neuroblastoma SY5Y and cervix adenocarcinoma HeLa S3. Toxicology 216 1 (2005) 1-8
26. Florea A.M., Yamoah E.N., and Dopp E. Intracellular calcium disturbances induced by arsenic and its methylated derivatives in relation to genomic damage and apoptosis induction. Environ Health Perspect 113 6 (2005) 659-664
27. 3) induced calcium signals and cellular death in two human SY-5Y Neuroblastoma and 293 embryonic kidney (HEK) cells. TAAP May 220 (2007) 292-301
28. Fuertesa M.A., Castillab J., Alonsoa C., and Pérez J.M. Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med Chem 10 February (3) (2003) 257-266
29. Gonzalez V.M., Fuertes M.A., Alonso C., and Perez J.M. Is cisplatin-induced cell death always produced by apoptosis?. Mol Pharmacol 59 April (4) (2001) 657-663
30. Guggenheim E.R., Xu D., Zhang C.X., Chang P.V., and Lippard S.J. Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA. Chembiochem 10 1 (2009) 141-157
31. i) and cytotoxicity. Neurotoxicology 30 2 (2009) 194-202
32. Hartmann J.T., and Lipp H.P. Toxicity of platinum compounds. Expert Opin Pharmacother 4 June (6) (2003) 889-901
33. Henkels K.M., and Turchi J.J. Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines. Cancer Res 57 (1997) 4488-4492
34. Henkels K.M., and Turchi J.J. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. Cancer Res 59 (1999) 3077-3083
35. Jiang M., Yi X., Hsu S., Wang C.Y., and Dong Z. Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity. Am J Physiol Renal Physiol 287 December (6) (2004) F1140-F1147
36. Johnson S.W., Laub P.B., Beesley J.S., Ozols R.F., and Hamilton T.C. Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines. Cancer Res 57 (1997) 850-856
37. Kawai Y., Nakao T., Kunimura N., Kohda Y., and Gemba M. Relationship of intracellular calcium and oxygen radicals to cisplatin-related renal cell injury. J Pharmacol Sci 100 (2006) 65-72
38. Kitchin K.T. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 172 3 (2001) 249-261
39. Liu S.X., Davidson M.M., Tang X., Walker W.F., Athar M., Ivanov V., et al. Mitochondrial damage mediates genotoxicity of arsenic in mammalian cells. Cancer Res 65 (2005) 3236-3242
40. Li J.J., Tang Q., Li Y., Hu B.R., Ming Z.Y., Fu Q., et al. Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid. Acta Pharmacol Sin 27 (2006) 1078-1084
41. Ma X.D., Qiao D.F., Tian X.M., Yan F., and Ma A.D. Mechanism of opening of mitochondrial permeability transition pore induced by arsenic trioxide. Ai Zheng 25 1 (2006) 17-21
42. Mattson M.P., LaFerla F.M., Chan S.L., Leissring M.A., Shepel P.N., and Geiger J.D. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci 23 5 (2000) 222-229
43. NRC. Arsenic in drinking water (1999), National Academy Press, Washington, DC p. 310
44. Ohnishi K. PML-RARalpha inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia. Int J Clin Oncol 12 October (5) (2007) 313-317
45. Orrenius S., Zhivotovsky B., and Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 4 7 (2003) 552-565
46. Piacentini R., Gangitano C., Ceccariglia S., Fà A.D., Azzena G.B., Michetti F., et al. Dysregulation of intracellular calcium homeostasis is responsible for neuronal death in an experimental model of selective hippocampal degeneration induced by trimethyltin. J Neurochem 105 6 (2008) 2109-2121
47. Park M.S., De Leon M., and Devarajan P. Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol 13 April (4) (2002) 858-865
48. Patanow C.M., Day J.R., and Billingsley M.L. Alterations in hippocampal expression of SNAP-25, GAP-43, stannin and glial fibrillary acidic protein following mechanical and trimethyltin-induced injury in the rat. Neuroscience 76 (1997) 187-202
49. Philbert M.A., Billingsley M.L., and Reuhl K.R. Mechanisms of injury in the central nervous system. Toxicol Pathol 28 January-February (1) (2000) 43-53
50. Rana S.V. Metals and apoptosis: recent developments. J Trace Elem Med Biol 22 4 (2008) 262-284
51. Roboz G.J. Arsenic and old lace: novel approaches in elderly patients with acute myeloid leukemia. Semin Hematol 45 3 (Suppl. 2) (2008) S22-S24
52. Syng-ai C., Basu Baul T.S., and Chatterjee A. Antiproliferative and cytotoxic effect of a novel organotin compound on mammalian cells both in vitro and in vivo. Mutat Res 513 1-2 (2002) 49-55
53. 3. Int J Mol Med 9 4 (2002) 385-390
54. Shintani N., Ogita K., Hashimoto H., and Baba A. Recent studies on the trimethyltin actions in central nervous systems. Yakugaku Zasshi 127 March (3) (2007) 451-461
55. Sorenson C.M., and Eastman A. Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells. Cancer Res 48 (1988) 6703-6707
56. 2+-influx in HeLa-S3 cells and prevents activation of calpain. Br J Pharmacol 151 (2007) 1176-1186
57. Tachikawa T., Kumazawa H., Hori Y., Harada N., Sai S., Yamashita T., et al. Intracellular calcium changes and chemosensitivities of human epidermoid carcinoma cell lines after exposure to cisplatin. Ann Otol Rhinol Laryngol 107 July (7) (1998) 611-618
58. Tomaszewski A., and Büsselberg D. Cisplatin modulates voltage gated channel currents of dorsal root ganglion neurons of rats. Neurotoxicology 28 January (1) (2007) 49-58
59. 2 reduces voltage-activated calcium channel currents of dorsal root ganglion neurons of rats. Neurotoxicology 29 November (6) (2008) 958-963
60. Tallman M.S. The expanding role of arsenic in acute promyelocytic leukemia. Semin Hematol 45 3 (Suppl. 2) (2008) S25-S29
61. Trimmer E.E., and Essigmann J.M. Cisplatin Essays Biochem 34 (1999) 191-211
62. Yu X., Robinson J.F., Gribble E., Hong S.W., Sidhu J.S., and Faustman E.M. Gene expression profiling analysis reveals arsenic-induced cell cycle arrest and apoptosis in p53-proficient and p53-deficient cells through differential gene pathways. Toxicol Appl Pharmacol 233 3 (2008) 389-403
63. Wang Z.Y., and Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111 5 (2008) 2505-2515
64. White J.S., Tobin J.M., and Cooney J.J. Organotin compounds and their interactions with microorganisms. Can J Microbiol 45 July (7) (1999) 541-554
65. Qian Y., Castranova V., and Shi X. New perspectives in arsenic-induced cell signal transduction. J Inorg Biochem 96 2-3 (2003) 271-278
66. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P., and Waalkes M.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci USA 94 20 (1997) 10907-10912
67. Zheng P.Z., Wang K.K., Zhang Q.Y., Huang Q.H., Du Y.Z., Zhang Q.H., et al. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukaemia. Proc Natl Acad Sci USA 102 21 (2005) 7653-7658